Clincosm LogoSign in Get a demo

Hematologic Malignancies

Showing NaN - NaN of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancies Trial in United States (ProHema-CB, Untreated CB)

Terminated
  • Hematologic Malignancies
  • ProHema-CB
  • Untreated CB
  • Duarte, California
  • +10 more
Nov 26, 2021

Hematologic Malignancies, Hypoproliferative Thrombocytopenia Trial in United States (Mirasol platelets (MIR PLTs), Reference

Terminated
Has Results
  • Hematologic Malignancies
  • Hypoproliferative Thrombocytopenia
  • Mirasol platelets (MIR PLTs)
  • Reference platelets (REF PLTs)
  • Washington, District of Columbia
  • +9 more
Jul 28, 2021

Cancer, Hematologic Malignancies, Multiple Myeloma Trial in Worldwide (Denosumab, Zoledronic acid, Placebo to Denosumab)

Completed
Has Results
  • Cancer
  • +5 more
  • Tucson, Arizona
  • +308 more
Mar 19, 2020

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome, Hematologic Malignancies Trial in France, United States (AG881)

Completed
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Aurora, Colorado
  • +5 more
Mar 6, 2019

Tumors, Hematologic Malignancies Trial in Worldwide (Atezolizumab)

Completed
  • Tumors
  • Hematologic Malignancies
  • Scottsdale, Arizona
  • +20 more
Dec 10, 2018

Hematologic Malignancies Trial in Duarte, Boston (Biological: ProHema-CB)

Terminated
Has Results
  • Hematologic Malignancies
  • Biological: ProHema-CB
  • Duarte, California
  • +1 more
Feb 28, 2018

Hematologic Malignancies Trial in New Haven, Boston, San Antonio (procedure, drug, radiation)

Completed
Has Results
  • Hematologic Malignancies
  • extracorporeal photopheresis
  • +2 more
  • New Haven, Connecticut
  • +2 more
Nov 23, 2016

Hematologic Malignancies Trial in Boston (CliniMACS CD25 Reagent Device)

Completed
  • Hematologic Malignancies
  • CliniMACS CD25 Reagent Device
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Sep 28, 2016

Hematologic Malignancies, Allogeneic Stem Cell Transplantation Trial in Boston (Fludarabine, Melphalan, Antithymocyte Globulin)

Completed
  • Hematologic Malignancies
  • Allogeneic Stem Cell Transplantation
  • Boston, Massachusetts
  • +1 more
Oct 7, 2013

Hematologic Malignancies Trial in Boston (Bortezomib (Velcade), Tacrolimus, Methotrexate)

Completed
Has Results
  • Hematologic Malignancies
  • Bortezomib (Velcade)
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jun 19, 2013

GVHD, Hematologic Malignancies Trial in Boston (Sirolimus, Tacrolimus, Methotrexate)

Completed
  • Graft Versus Host Disease
  • Hematologic Malignancies
  • Boston, Massachusetts
  • +2 more
Mar 6, 2012

Hematologic Malignancies, Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Boston (Sirolimus, Tacrolimus)

Completed
  • Hematologic Malignancies
  • +5 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 24, 2012

Hematologic Malignancies Trial in Boston (Darbepoetin alfa)

Completed
  • Hematologic Malignancies
  • Darbepoetin alfa
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 12, 2009